Samantha serves as Co-CEO and is a Co-Founder of Cadence Health. She is a biopharmaceutical executive leader with more than two decades of experience mastering pharma partnering, product and technology acquisitions, corporate financing, strategic planning, commercial planning, supply chain negotiations, and regulatory management. Samantha started her career as a scientist, and quickly found her passion for building new biopharmaceutical companies. Samantha has deep entrepreneurial experience as well having served as Chief Business Officer for pharma start-ups InCarda Therapeutics and Dance Biopharm. She also led business development for mid-market ventures Theravance, Nektar, and Onyx, and values her early training at P&G Pharmaceuticals. Samantha holds a BS in Biochemistry & Cell Biology from the University of California, San Diego, an MS in Immunology and an MBA in Finance from the University of Rochester.